Belgium in negotiations with Merck for the purchase of 10,000 doses of Molnupiravir
A work group “Covid Therapeutics“was set up at the federal level within the Center of Expertise for Health Care (KCE), communicated Wednesday the office of the Minister of Public Health Frank Vandenbroucke. It will have to coordinate the purchase and the good use of the drugs of Of the Covid-19 which are announced for the next weeks of treatment and months.
The new group is headed by Dirk Ramaekers, who is already part of the vaccination taskforce.
►►► To read: Molnupiravir, the hope of a pill against the Covid-19?
A first opinion on the drug developed by the company Merck, Molnupiravir, “is in preparation“. The European Medicines Agency, EMA, began a formal review last week of this oral antiviral which will be marketed under the name”Lagevrio“, with a view to an authorization for placing on the European market.
Belgium is already in negotiations with Merck for a “first purchase of 10,000 doses of Molnupiravir“, informs the cabinet Vandenbroucke. An order which should”become part of a common European approach as soon as the European approach is launched“.